Inventor · disambiguated record
Nicolin Bloch
Also filed as: BLOCH NICOLIN
2 granted patents·7 pending applications·0 citations·filing 2021–2024
32Inventor score
Files withREGENERON PHARMA9
Top patents by PatentIndex Score
9 records- 0182US12168681B2Il-2 variants with reduced binding to IL-2 receptor alpha and uses thereofREGENERON PHARMA·Filed 2023·Granted Dec 17, 2024·0 cites·5 claims
- 0278US2025296969A1Il-2 variants with reduced binding to il-2 receptor alpha and uses thereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0370US11834485B2IL-2 variants with reduced binding to IL-2 receptor alpha and uses thereofREGENERON PHARMA·Filed 2021·Granted Dec 5, 2023·0 cites·25 claims
- 0470US2024067691A1Interferon receptor agonists and uses thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0570US2024101633A1Interferon receptor agonists and uses thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0667US2024277844A1Induced nk cells responsive to cd3/taa bispecific antibodiesREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0765US2024376229A1Interferon receptor antagonists and uses thereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0863US2023391844A1Interleukin-2 proproteins and uses thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0957US2023110958A1Il27 receptor agonists and methods of use thereofREGENERON PHARMA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicolin Bloch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →